SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-18-006054
Filing Date
2018-05-07
Accepted
2018-05-07 16:29:59
Documents
4
Period of Report
2018-05-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k050118.htm 8-K 36667
2 EXHIBIT 10.1 ex101.htm EX-10.1 13471
3 EXHIBIT 10.2 ex102.htm EX-10.2 13037
4 EXHIBIT 10.3 ex103.htm EX-10.3 13019
  Complete submission text file 0001628280-18-006054.txt   77605
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 18811628
SIC: 2834 Pharmaceutical Preparations